|
Status |
Public on Jun 30, 2022 |
Title |
EBF1 contributes to the balance of lympho-myeloid fate in haematopoietic progenitors via B-lymphoid priming and Cebpa antagonism |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing Genome variation profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
36048017 |
|
Submission date |
Nov 18, 2021 |
Last update date |
Oct 04, 2022 |
Contact name |
Aurelie Lenaerts |
E-mail(s) |
lenaerts@ie-freiburg.mpg.de
|
Organization name |
Max Planck Institute of Immunobiology and Epigenetics
|
Department |
Cellular and Molecular Immunology
|
Lab |
Laboratory Rudolf Grosschedl
|
Street address |
Stübeweg 51
|
City |
Freiburg |
ZIP/Postal code |
79108 |
Country |
Germany |
|
|
Platforms (1) |
GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
Samples (32)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE188884 |
EBF1 contributes to the balance of lympho-myeloid fate in haematopoietic progenitors via B-lymphoid priming and Cebpa antagonism [Bulk RNA-seq] |
GSE189049 |
EBF1 contributes to the balance of lympho-myeloid fate in haematopoietic progenitors via B-lymphoid priming and Cebpa antagonism [ATAC-seq] |
GSE189051 |
EBF1 contributes to the balance of lympho-myeloid fate in haematopoietic progenitors via B-lymphoid priming and Cebpa antagonism [10x] |
|
Relations |
BioProject |
PRJNA781462 |